TLDR:
- Super funds Hostplus and HESTA, biotech giant CSL, and Queensland Investment Corporation invest $270 million into venture capital fund for Brandon Capital.
- Brandon Capital aims to raise $350 million for its latest fund, Brandon Biocatalyst 6.
Article Summary:
Superannuation funds Hostplus and HESTA, along with biotech company CSL and Queensland Investment Corporation, have collectively invested $270 million into Brandon Capital’s venture capital fund. Brandon Capital, known as Australia’s largest life science investment fund, started with a $30 million fund in 2007 and has raised over $1 billion across its funds for healthcare and biotech start-ups. The latest fund, named Brandon Biocatalyst 6, aims to raise a total of $350 million.
